Does SAVR or TAVI reduce mortality in older adults with symptomatic severe calcific aortic stenosis?
Older adults with symptomatic severe calcific aortic stenosis
Surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI)
Mortalityhard clinical
SAVR and TAVI are life-saving interventions for symptomatic severe calcific aortic stenosis, reducing mortality to match age-matched controls.
Calcific AS is a common chronic progressive condition among older adults and is diagnosed via echocardiography. Symptomatic patients with severe AS have a mortality rate of up to 50% after 1 year, but treatment with SAVR or TAVI reduces mortality to that of age-matched control patients. The type and timing of valve replacement should be built on evidence-based guidelines, shared decision-making, and involvement of a multidisciplinary heart valve team.
Building similarity graph...
Analyzing shared references across papers
Loading...
Catherine M Otto
David E. Newby
Graham S. Hillis
JAMA
University of Washington
University of Edinburgh
The University of Western Australia
Building similarity graph...
Analyzing shared references across papers
Loading...
Otto et al. (Mon,) studied this question.
www.synapsesocial.com/papers/69c7f3881b47d466e5369c9f — DOI: https://doi.org/10.1001/jama.2024.16477